April 25-26,2019Day one morning-Global Industry trends
Day one afternoon to Day two
Stream A-- Drug Substance
Stream B-- Formulation Design and development
Stream C-- Analytical Development and Support
Stream D-- Regulatory Planning Session
Stream E-- BE Studies Session
Protech Pharmaservices Corporation (PPC)was founded in 1997 in Taipei, Taiwan to meet the growing demands for R&Doutsourcing from the Pharmaceutical and Biotech industries in the Asia-Pacificregion. Working with its worldwide customers as a leading regional ContractResearch Organization (CRO), PPC group provides professional services in“Clinical Research” (Phases I to IV) and “Contract Laboratories” (Central andBio-analytical Labs).
Shanghai Bocimed Pharmaceutical Co., Ltd., located in Shanghai Zhangjiang High-Tech Park, is a high-tech enterprise certificated by Shanghai government. In the R&D team with more than 100 members, 40% have Ph.D. or Master Degree. The R&D center of the company is more than 2500m2, and the investment for the facilities is above 20 million RMB. Bocimed is among the earliest which has got the ISO9001:2015 certification.
The company is engaged in the whole process of drug development including R&D of high-end generic drugs, quality consistency evaluation for generic drugs, clinical research and registration service, and provides pharmaceutical companies as well as the company itself with highly-competitive new drugs.
In the 10 years after the company was founded, Bocimed has established cooperation with about 100 local and foreign pharmaceutical companies and has got good reputation. Bocimed is also listed in Top 50 pharmaceutical R&D enterprises in China.
ViaClinical Ltd is a clinical CRO specializing in bioequivalence studies and provides services to pharmaceutical companies and R&D institutions to conduct Assessment for Quality and Interchangeability between generic and brand drug products. We havesuccessful experiences in the WHO program for Prequalification of Medicines, as well as CFDA submissions. We work with GCP and GLP compliant clinical sites in China and India.
DXC Technology is the world’s leading business transformation company, helping clients harness the power of innovation to thrive on change. Born of the merger of CSC and the Enterprise Services business of Hewlett Packard Enterprise, DXC serves nearly 6,000 private and public-sector enterprises across 70 countries. DXC’s technology independence, global talent, expertise, and extensive alliance of partners combine to deliver the most powerful end-to-end next-generation IT services and solutions.
We are an experienced hand who has met the challenges of innovation many times before, and has a clear and confident vision for navigating the future.
We work with you, at your side, to solve complex challenges in ways that minimize business risk and maximize opportunity.
We operate differently: Our world-class talent becomes part of your team, innovating with you and putting the right technology to work for your organization. We bring along the industry’s best technology partners as integral members of our team. And we invest in building collaborative client relationships that flex and grow to help meet new challenges with confidence, speed and agility.